FOR patients without a history of cardiovascular disease, neither fish oil nor aspirin convey any benefit with relation to heart attacks, new Oxford University research says.
Fish oil supplements were "safe, but offered no added benefit," said Dr Bowman, professor of medicine and clinical trials at the university.
In the aspirin study, participants who took 100mg daily had a lower rate of cardiovascular events (down 12%), but it upped the risk of major bleeding by 29%, outweighing any benefit, authors said.
"The absolute benefits were largely counterbalanced by the bleeding hazard," said the team, led by Dr Jane Armitage, professor of clinical trials and epidemiology at Nuffield - CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 31 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Aug 18
